KRED

Monday, June 19, 2017

Kite Pharma Proxy Voting Guide – Corporate Governance

http://ift.tt/2ler3Yy

corpgov.net
– James McRitchie
200) && (this.width >= this.height) ? 200: true); max-height: 200px; height: expression((this.height > 200) && (this.height >= this.width) ? 200: true); border: none;’/>
Kite Pharma, Inc. (KITE), a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel cancer immunotherapy products. Kite is one of the stocks in my portfolio. ProxyDemocracy.org had collected the votes of no fund families when I checked and voted. Their annual meeting is coming up on June 20th, 2017. I voted FOR Proposal #3 to Declassify the Board. See how and why I voted other items below. I voted with the Board’s recommendations 43% of the time. View.  show all text
posted by friends:
 (3)
@WholeBoardDev on Twitter
@WholeBoardDev: Kite Pharma Proxy Voting Guide http://ift.tt/2sgKjdl; #corpgov $KITE Vote #3 declassify board (annual elections) S… http://twitter.com/i/web/status/8…
@ToGovern on Twitter
@ToGovern: Kite Pharma Proxy Voting Guide http://ift.tt/2sgKjdl; #corpgov $KITE Vote #3 declassify board (annual elections) S… http://twitter.com/i/web/status/8…
@corpgovnet on Twitter
@corpgovnet: Kite Pharma Proxy Voting Guide http://ift.tt/2sgKjdl; #corpgov $KITE Vote #3 declassify board (annual elections) S… http://twitter.com/i/web/status/8…
posted by followers of the list:
 (0)

Vía All News on ‘The Twitter Times: Muzaffar69/corpgov’ http://ift.tt/2sgzsjm